ALFA FinderNSE filing, NSE: SOUTHWEST. Summary written from the filing by ALFA Finder's alert engine.
South West Pinnacle Exploration Ltd: key numbers
- Share price
- ₹163.66
- Market cap
- ₹534.4 Cr
- Revenue (annual)
- ₹243.0 Cr
- Net profit (annual)
- ₹33.03 Cr
- P/E (TTM)
- 15.0×Sector 17.1×
- Promoter holding
- 61.70%-3.11% QoQ
- FII holding
- 0.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from South West Pinnacle Exploration Ltd
All →South West Pinnacle Exploration Earnings Call Transcript: Key Takeaways
Q2 weak (~₹58 Cr revenue, 14.38% EBITDA margin) on monsoon, maintenance and diesel costs. H1 revenue up 16.3% on a record ₹767 Cr order book. Management repeats its FY27 15-20% growth target with hedging and deflects promoter stake-sale questions.
South West Pinnacle Exploration Investor Presentation: Key Takeaways
H1 FY27 operating revenue INR 1,194 Mn at 19.43% EBITDA margin. Order book INR 7,671 Mn as of 30 Sep 2026, up from INR 5,812 Mn at FY26-end.
South West Pinnacle Exploration Results Update
South West Pinnacle Exploration reported H1 FY27 revenue of Rs.1194 Mn (up 16% YoY) and PAT of Rs.133 Mn (up 23%), with a record order book of INR 7,671 Mn. The release also highlights Jharkhand coal block progress and Oman JVs.
- Order book
- ₹767.1 Cr
South West Pinnacle Exploration Q2 FY27 Results: Net Profit ₹4 Cr, Down 52.4% YoY
South West Pinnacle Exploration Ltd reported revenue from operations of ₹57.7 Cr (-7.5% YoY) and net profit of ₹4 Cr (-52.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4 Cr · -52.4% YoY
South West Pinnacle Exploration Board Meeting Date
South West Pinnacle Exploration has scheduled its board meeting for November 6, 2026, to approve Q2 and H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
South West Pinnacle Exploration Convertible Warrants
South West Pinnacle obtained NSE and BSE trading approval for 28,21,411 warrant-conversion shares, listed from 29 October 2026. Allottees include promoters Vikas and Piyush Jain.
Other merger & restructuring announcements
All →Zydus Lifesciences Merger & Restructuring Worth ₹9.38 Cr
Zydus Lifesciences completed its ₹9.38 Crore 50% subscription in JV Zydus Sunshine Lifesciences. The transaction with Sunshine Healthcare Lanka was fully executed on November 11, 2026.
- Value
- ₹9.38 Cr
Zydus Lifesciences Merger & Restructuring
Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.
Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr
Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.
- Value
- ₹2.60 Cr
Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr
Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.
- Value
- ₹1.20 Cr
Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.